Can a drug and exercise combo help MS patients walk better?
NCT ID NCT06136728
First seen Mar 11, 2026 · Last updated May 14, 2026 · Updated 10 times
Summary
This study looks at whether taking a walking-improvement drug (dalfampridine) along with physical therapy helps people with multiple sclerosis walk better than either treatment alone. About 48 adults with MS who have trouble walking will first try the drug for 6 weeks, then stop for 2 weeks, and then be randomly assigned to 6 weeks of physical therapy either with or without the drug. Researchers will compare walking speed and function between the groups.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE SCLEROSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
MGH Institute of Health Professions
RECRUITINGBoston, Massachusetts, 02129, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.